Bixiye
Tezspire (tezepelumab-ekko) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Natiijooyinka Raadinta
Soo bandhiga 4101 - 4110 ee natiijooyinka 4294
Bixiye
Topical Corticosteroids - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Self-Administered Oncology Agents - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Sunosi (solriamfetol) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
GLP-1 (glucagon-like peptide-1) Agonists - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Interleukin-5 (IL-5) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Interleukin-4 (IL-4) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Immune Globulins - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Leqembi - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026
Bixiye
Radicava (edaravone) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2026